BridgeBio Pharma, Inc. (BBIO)

NASDAQ: BBIO · Real-Time Price · USD

68.39

-3.99 (-5.51%)

Sep 15, 2026, 4:00 PM EDT - Market closed

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Product Revenue	657.16M	362.37M	2.88M
License and Services Revenue	21.42M	128.32M	218.85M
Royalty Revenue	34.49M	11.39M	169.00K
Revenue (Total)	713.07M	502.08M	221.90M

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
U.S. - Geographic Revenue Distribution	72.20%	6.00%
Europe, Middle East, and Africa (EMEA) - Geographic Revenue Distribution	25.30%	59.50%
Asia-Pacific (APAC) - Geographic Revenue Distribution	2.50%	34.50%